4 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
Follow Tafolecimab: new trials by email Literature Review of Tafolecimab trials Research Report on Tafolecimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer Tafolecimab, Sintilimab - Colon Cancer, PCSK9 Inhibitor | Phase 2 | Recruiting | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 70 | 2026-09-20 | 2026-09-25 |
| Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer Disitamab vedotin, Toripalimab, Sitagliptin - Bladder Urothelial Carcinoma, Bladder Cancer | Phase 2 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 80 | 2026-07-01 | 2026-07-21 |
| Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer Tafolecimab, Sintilimab (approved), Etoposide - Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive Stage Lung Small Cell Cancer | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2025-07-30 | 2026-09-15 |
| A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. Tafolecimab, Sintilimab, Nab paclitaxel - Lung Cancer | Phase 2 | Recruiting | Jinghui Wang | 30 | 2024-05-17 | 2024-05-20 |
Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1) · Urinary Bladder Neoplasms (1)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · Jinghui Wang (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (4)